NOS2 and asthma: In the current study, we show that iNOS inhibition, by the selective inhibitor L-NIL and confirmed by the use of a gene knockout approach, provided an excellent protection against AHR upon an acute exposure but not upon a chronic exposure to allergens in two experimental asthma models.